Inflammatory bowel disease (IBD)

Inflammatory bowel disease (IBD) is a broad term for a group of chronic inflammatory conditions of the gastrointestinal (GI) tract. The two most common forms are Crohn's disease and ulcerative colitis. Both conditions are characterized by an abnormal immune response that causes the body to attack its own digestive tract, leading to prolonged inflammation and damage. While they share many symptoms, they differ in the location and nature of the inflammation. Ulcerative colitis is confined to the large intestine (the colon and rectum), where it causes continuous inflammation affecting only the innermost lining of the intestinal wall. In contrast, Crohn's disease can affect any part of the GI tract, from the mouth to the anus, and the inflammation can occur in patches, penetrating the full thickness of the bowel wall.

The symptoms of IBD vary depending on the location and severity of inflammation but commonly include persistent diarrhea (which may be bloody), abdominal pain and cramping, rectal bleeding, urgent need to move the bowels, fatigue, and unintended weight loss. The disease typically follows a pattern of active periods, known as flares, followed by periods of remission where symptoms subside. The unpredictable nature of these flares can significantly impact a person's daily life, work, and social activities.

The exact cause of IBD is unknown, but it is considered an autoimmune-like condition resulting from a complex interplay of genetic susceptibility, environmental triggers (such as diet, smoking, or infections), and a dysregulated immune system. It is believed that in genetically predisposed individuals, an environmental factor triggers an inappropriate and ongoing immune attack against the harmless bacteria that normally reside in the gut. It is crucial to distinguish IBD from irritable bowel syndrome (IBS). While both can cause abdominal discomfort and changes in bowel habits, IBD involves demonstrable inflammation and physical damage to the GI tract, which can be seen on imaging or endoscopy. IBS, on the other hand, is a functional disorder of gut-brain interaction without visible inflammation or tissue damage.

For patients, IBD is a lifelong condition that requires ongoing medical management to control symptoms, induce and maintain remission, and prevent complications. Treatment strategies are tailored to the individual and may include anti-inflammatory drugs, immune system suppressors, and advanced biologic therapies that target specific inflammatory pathways. In some cases, surgery may be necessary to remove severely damaged sections of the intestine or to treat complications like strictures or fistulas. Living with IBD can pose significant physical and emotional challenges, but with proper management, most individuals can lead full and productive lives. Furthermore, long-standing inflammation, particularly in the colon, increases the risk of developing colorectal cancer, necessitating regular surveillance colonoscopies for many patients.